Real-time enrollment status for this neuroendocrine carcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:46 AM UTC
| NCT Number | NCT06889493 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Peter Hosein, MD |
| Last Updated on CT.gov | April 28, 2026 (Apr 28, 2026) |
As of July 18, 2026: Clinical trial NCT06889493 is currently recruiting participants. This phase1 study for neuroendocrine carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Peter Hosein, MD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06889493 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06889493 was last updated Apr 28, 2026 (April 28, 2026). HelloStudys verifies this status automatically.